Baird Upgrades Humana to Outperform, Raises Price Target to $596
10/9/2026
Impact: 80
Healthcare
Baird analyst Michael Ha has upgraded Humana (NYSE: HUM) from Neutral to Outperform. Additionally, the price target for the stock has been raised significantly from $390 to $596.
AI summary, not financial advice
Share: